BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1908891)

  • 1. Duration of etidronate effect demonstrated by serial bone scintigraphy.
    Sandler ED; Parisi MT; Hattner RS
    J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
    Hommeyer SH; Varney DM; Eary JF
    J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
    Murphy KJ; Line BR; Malfetano J
    Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etidronate sodium therapy--a cause of poor skeletal radiopharmaceutical uptake.
    DeMeo JH; Balseiro J; Cole TJ
    Semin Nucl Med; 1991 Oct; 21(4):332-4. PubMed ID: 1754895
    [No Abstract]   [Full Text] [Related]  

  • 5. False-negative bone imaging due to etidronate disodium therapy.
    Krasnow AZ; Collier BD; Isitman AT; Hellman RS; Ewey D
    Clin Nucl Med; 1988 Apr; 13(4):264-7. PubMed ID: 3131057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat.
    Watt I; Hill P
    Br J Radiol; 1981 Jul; 54(643):592-6. PubMed ID: 6455174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
    de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etidronate for hypercalcemia of malignancy and osteoporosis.
    Horowitz E; Miller JL; Rose LI
    Am Fam Physician; 1991 Jun; 43(6):2155-9. PubMed ID: 1904188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry.
    Meunier PJ; Chapuy MC; Delmas P; Charhon S; Edouard C; Arlot M
    Am J Med; 1987 Feb; 82(2A):71-8. PubMed ID: 3103438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
    Chong WK; Cunningham DA
    Clin Radiol; 1991 Oct; 44(4):268-70. PubMed ID: 1835685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
    Kawamura J; Tochigi H; Yanagawa M; Yoshida O; Hida S; Mori O; Suzuki N; Saito K; Komatsu Y; Hatayama T
    Hinyokika Kiyo; 1988 Mar; 34(3):528-37. PubMed ID: 3133934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
    Basoglu T; Canbaz F; Bernay I
    J Nucl Med; 1998 Dec; 39(12):2034, 5A. PubMed ID: 9867137
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
    Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
    Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical etidronate treatment of osteoporosis.
    N Engl J Med; 1990 Dec; 323(23):1633-5. PubMed ID: 2122254
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
    Lee JY
    Clin Nucl Med; 1981 Aug; 6(8):356-8. PubMed ID: 6455232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual scintigraphic findings in a case of treated monostotic Paget's disease.
    Ziewacz JT; Slavin JD; Spencer RP
    Clin Nucl Med; 1988 Feb; 13(2):93-5. PubMed ID: 3127101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.